Pacer Advisors Inc. Decreases Stock Position in Humana Inc. $HUM

Pacer Advisors Inc. lessened its position in shares of Humana Inc. (NYSE:HUM) by 25.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,499 shares of the insurance provider’s stock after selling 3,284 shares during the period. Pacer Advisors Inc.’s holdings in Humana were worth $1,647,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Montag A & Associates Inc. increased its holdings in Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after acquiring an additional 94 shares during the last quarter. Fideuram Asset Management Ireland dac purchased a new stake in Humana during the fourth quarter valued at about $27,000. Reflection Asset Management purchased a new stake in Humana during the fourth quarter valued at about $29,000. Larson Financial Group LLC boosted its position in Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares during the period. Finally, Fulcrum Asset Management LLP purchased a new position in shares of Humana in the third quarter worth about $42,000. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE HUM opened at $384.44 on Friday. The stock’s 50-day simple moving average is $377.18 and its two-hundred day simple moving average is $271.65. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The firm has a market capitalization of $46.16 billion, a P/E ratio of 36.37, a P/E/G ratio of 2.20 and a beta of 0.72. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter last year, the company posted $6.27 EPS. The company’s revenue for the quarter was up 26.2% on a year-over-year basis. As a group, equities analysts anticipate that Humana Inc. will post 9.08 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Truist Financial boosted their price target on shares of Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Seaport Research Partners lowered shares of Humana to a “neutral” rating in a research note on Wednesday, May 20th. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a report on Thursday, July 30th. Jefferies Financial Group upgraded Humana from a “buy” rating to a “buy” rating in a research report on Wednesday, May 20th. Finally, Wells Fargo & Company upgraded Humana from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $227.00 to $502.00 in a research report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, fourteen have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $391.87.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.